Cargando…

NADP(+) is an endogenous PARP inhibitor in DNA damage response and tumor suppression

ADP-ribosylation is a unique posttranslational modification catalyzed by poly(ADP-ribose) polymerases (PARPs) using NAD(+) as ADP-ribose donor. PARPs play an indispensable role in DNA damage repair and small molecule PARP inhibitors have emerged as potent anticancer drugs. However, to date, PARP inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Chunjing, Zhang, Chao, Luo, Tao, Vyas, Aditi, Chen, Shih-Hsun, Liu, Chao, Kassab, Muzaffer Ahmad, Yang, Ying, Kong, Mei, Yu, Xiaochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370829/ https://www.ncbi.nlm.nih.gov/pubmed/30741937 http://dx.doi.org/10.1038/s41467-019-08530-5

Ejemplares similares

PARP2 mediates branched poly ADP-ribosylation in response to DNA damage
por: Chen, Qian, et al.
Publicado: (2018)

The role of poly ADP-ribosylation in the first wave of DNA damage response
por: Liu, Chao, et al.
Publicado: (2017)

Super-resolution imaging identifies PARP1 and the Ku complex acting as DNA double-strand break sensors
por: Yang, Guang, et al.
Publicado: (2018)

Targeting dePARylation selectively suppresses DNA repair–defective and PARP inhibitor–resistant malignancies
por: Chen, Shih-Hsun, et al.
Publicado: (2019)

The PIN domain of EXO1 recognizes poly(ADP-ribose) in DNA damage response
por: Zhang, Feng, et al.
Publicado: (2015)

PGC7 suppresses TET3 for protecting DNA methylation
por: Bian, Chunjing, et al.
Publicado: (2014)

NADP(H)-dependent biocatalysis without adding NADP(H)
por: Herold, Ryan A., et al.
Publicado: (2022)

NADP(H) allosterically regulates the interaction between ferredoxin and ferredoxin‐NADP(+) reductase
por: Kimata‐Ariga, Yoko, et al.
Publicado: (2019)

PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022)

Dynamics of endogenous PARP1 and PARP2 during DNA damage revealed by live-cell single-molecule imaging
por: Mahadevan, Jyothi, et al.
Publicado: (2022)

PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs
por: Wang, Luyao, et al.
Publicado: (2017)

Crystal structures of Leptospira interrogans FAD-containing ferredoxin-NADP(+ )reductase and its complex with NADP(+)
por: Nascimento, Alessandro S, et al.
Publicado: (2007)

Poly(ADP-ribose) protects vascular smooth muscle cells from oxidative DNA damage
por: Zhang, Chao, et al.
Publicado: (2015)

Targeting dePARylation for cancer therapy
por: Kassab, Muzaffer Ahmad, et al.
Publicado: (2020)

Mitochondrial NADP(+)-dependent isocitrate dehydrogenase deficiency increases cisplatin-induced oxidative damage in the kidney tubule cells
por: Kong, Min Jung, et al.
Publicado: (2018)

Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo
por: Shao, Zhengping, et al.
Publicado: (2020)

Nanomechanical Study of Enzyme: Coenzyme Complexes: Bipartite Sites in Plastidic Ferredoxin-NADP(+) Reductase for the Interaction with NADP(+)
por: Pérez-Domínguez, Sandra, et al.
Publicado: (2022)

Apollo-NADP(+) reveals in vivo adaptation of NADPH/NADP(+) metabolism in electrically activated pancreatic β cells
por: Bui, Cindy V., et al.
Publicado: (2023)

Fitting data reveals the complexities of NADP as a Ca(2+) ATPase inhibitor
por: Guerrero‐Hernandez, Agustin
Publicado: (2019)

New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage
por: Gu, Zongying, et al.
Publicado: (2019)

PARP-1 inhibitors enhance the chemosensitivity of leukemia cells by attenuating NF- кB pathway activity and DNA damage response induced by Idarubicin : PARP-1 inhibitors attenuate DNA damage response
por: Ke, Bo, et al.
Publicado: (2021)

PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response
por: Kim, Chiho, et al.
Publicado: (2020)

PARP inhibitors
por: Anwar, Maheen, et al.
Publicado: (2015)

Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer
por: Tang, Bin, et al.
Publicado: (2023)

Structure modeling and inhibitor prediction ofNADP oxidoreductase enzyme from Methanobrevibacter smithii
por: Sharma, Ashwani, et al.
Publicado: (2011)

Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
por: Francica, Paola, et al.
Publicado: (2018)

PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures
por: McNevin, Ciara S., et al.
Publicado: (2022)

Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment
por: Li, Yuan, et al.
Publicado: (2019)

BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair
por: Zhang, Shaolu, et al.
Publicado: (2021)

Truncated PARP1 mediates ADP-ribosylation of RNA polymerase III for apoptosis
por: Chen, Qian, et al.
Publicado: (2022)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer
por: Yamaguchi, Hirohito, et al.
Publicado: (2017)

Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin
por: Hanzlikova, Hana, et al.
Publicado: (2017)

Strategic Combination of DNA-Damaging Agent and PARP Inhibitor Results in Enhanced Cytotoxicity
por: Horton, Julie K., et al.
Publicado: (2013)

The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
por: Park, Hye Jeong, et al.
Publicado: (2018)

Introducing the 3(rd) Annual PARP and DNA Damage Response Inhibitors Summit
Publicado: (2020)

PARP inhibitors: the race is on
por: Brown, Jessica S, et al.
Publicado: (2016)

Purification and Characterization of Cytoplasmic NADP(+)-Isocitrate Dehydrogenase, and Amplification of the Nadp(+)-IDH Gene from the Wing-Dimorphic Sand Field Cricket, Gryllus firmus
por: Zera, Anthony J., et al.
Publicado: (2011)

High-Throughput Screening of Coenzyme Preference Change of Thermophilic 6-Phosphogluconate Dehydrogenase from NADP(+) to NAD(+)
por: Huang, Rui, et al.
Publicado: (2016)

HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer
por: Ma, Hanlin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1mla8612urppt9k82bka5fhdel